203 related articles for article (PubMed ID: 28507313)
1. Chronic intrahypothalamic rather than subcutaneous liraglutide treatment reduces body weight gain and stimulates the melanocortin receptor system.
Kaineder K; Birngruber T; Rauter G; Obermüller B; Eichler J; Münzker J; Al-Zoughbi W; Mautner SI; Torekov SS; Hartmann B; Kotzbeck P; Pieber TR
Int J Obes (Lond); 2017 Aug; 41(8):1263-1270. PubMed ID: 28507313
[TBL] [Abstract][Full Text] [Related]
2. GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK.
Beiroa D; Imbernon M; Gallego R; Senra A; Herranz D; Villarroya F; Serrano M; Fernø J; Salvador J; Escalada J; Dieguez C; Lopez M; Frühbeck G; Nogueiras R
Diabetes; 2014 Oct; 63(10):3346-58. PubMed ID: 24917578
[TBL] [Abstract][Full Text] [Related]
3. Antiobesity efficacy of GLP-1 receptor agonist liraglutide is associated with peripheral tissue-specific modulation of lipid metabolic regulators.
Decara J; Arrabal S; Beiroa D; Rivera P; Vargas A; Serrano A; Pavón FJ; Ballesteros J; Dieguez C; Nogueiras R; Rodríguez de Fonseca F; Suárez J
Biofactors; 2016 Nov; 42(6):600-611. PubMed ID: 27213962
[TBL] [Abstract][Full Text] [Related]
4. Liraglutide Activates Type 2 Deiodinase and Enhances β3-Adrenergic-Induced Thermogenesis in Mouse Adipose Tissue.
Oliveira FCB; Bauer EJ; Ribeiro CM; Pereira SA; Beserra BTS; Wajner SM; Maia AL; Neves FAR; Coelho MS; Amato AA
Front Endocrinol (Lausanne); 2021; 12():803363. PubMed ID: 35069450
[TBL] [Abstract][Full Text] [Related]
5. Cooperative role of the glucagon-like peptide-1 receptor and β3-adrenergic-mediated signalling on fat mass reduction through the downregulation of PKA/AKT/AMPK signalling in the adipose tissue and muscle of rats.
Decara J; Rivera P; Arrabal S; Vargas A; Serrano A; Pavón FJ; Dieguez C; Nogueiras R; Rodríguez de Fonseca F; Suárez J
Acta Physiol (Oxf); 2018 Apr; 222(4):e13008. PubMed ID: 29193738
[TBL] [Abstract][Full Text] [Related]
6. The key role of a glucagon-like peptide-1 receptor agonist in body fat redistribution.
Zhao L; Zhu C; Lu M; Chen C; Nie X; Abudukerimu B; Zhang K; Ning Z; Chen Y; Cheng J; Xia F; Wang N; Jensen MD; Lu Y
J Endocrinol; 2019 Feb; 240(2):271-286. PubMed ID: 30530905
[TBL] [Abstract][Full Text] [Related]
7. Liraglutide, a GLP-1 Receptor Agonist, Which Decreases Hypothalamic 5-HT2A Receptor Expression, Reduces Appetite and Body Weight Independently of Serotonin Synthesis in Mice.
Nonogaki K; Kaji T
J Diabetes Res; 2018; 2018():6482958. PubMed ID: 29484303
[TBL] [Abstract][Full Text] [Related]
8. The dual amylin and calcitonin receptor agonist KBP-089 and the GLP-1 receptor agonist liraglutide act complimentarily on body weight reduction and metabolic profile.
Larsen AT; Gydesen S; Sonne N; Karsdal MA; Henriksen K
BMC Endocr Disord; 2021 Jan; 21(1):10. PubMed ID: 33413317
[TBL] [Abstract][Full Text] [Related]
9. The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss.
Secher A; Jelsing J; Baquero AF; Hecksher-Sørensen J; Cowley MA; Dalbøge LS; Hansen G; Grove KL; Pyke C; Raun K; Schäffer L; Tang-Christensen M; Verma S; Witgen BM; Vrang N; Bjerre Knudsen L
J Clin Invest; 2014 Oct; 124(10):4473-88. PubMed ID: 25202980
[TBL] [Abstract][Full Text] [Related]
10. Glucagon-like peptide-1 regulates brown adipose tissue thermogenesis via the gut-brain axis in rats.
Krieger JP; Santos da Conceição EP; Sanchez-Watts G; Arnold M; Pettersen KG; Mohammed M; Modica S; Lossel P; Morrison SF; Madden CJ; Watts AG; Langhans W; Lee SJ
Am J Physiol Regul Integr Comp Physiol; 2018 Oct; 315(4):R708-R720. PubMed ID: 29847161
[TBL] [Abstract][Full Text] [Related]
11. Ventromedial hypothalamic melanocortin receptor activation: regulation of activity energy expenditure and skeletal muscle thermogenesis.
Gavini CK; Jones WC; Novak CM
J Physiol; 2016 Sep; 594(18):5285-301. PubMed ID: 27126579
[TBL] [Abstract][Full Text] [Related]
12. Nicotine improves obesity and hepatic steatosis and ER stress in diet-induced obese male rats.
Seoane-Collazo P; Martínez de Morentin PB; Fernø J; Diéguez C; Nogueiras R; López M
Endocrinology; 2014 May; 155(5):1679-89. PubMed ID: 24517227
[TBL] [Abstract][Full Text] [Related]
13. Contribution of brown adipose tissue activity to the control of energy balance by GLP-1 receptor signalling in mice.
Heppner KM; Marks S; Holland J; Ottaway N; Smiley D; Dimarchi R; Perez-Tilve D
Diabetologia; 2015 Sep; 58(9):2124-32. PubMed ID: 26049402
[TBL] [Abstract][Full Text] [Related]
14. Liraglutide suppresses obesity and induces brown fat-like phenotype via Soluble Guanylyl Cyclase mediated pathway in vivo and in vitro.
Zhu E; Yang Y; Zhang J; Li Y; Li C; Chen L; Sun B
Oncotarget; 2016 Dec; 7(49):81077-81089. PubMed ID: 27835589
[TBL] [Abstract][Full Text] [Related]
15. Patients with Obesity Caused by Melanocortin-4 Receptor Mutations Can Be Treated with a Glucagon-like Peptide-1 Receptor Agonist.
Iepsen EW; Zhang J; Thomsen HS; Hansen EL; Hollensted M; Madsbad S; Hansen T; Holst JJ; Holm JC; Torekov SS
Cell Metab; 2018 Jul; 28(1):23-32.e3. PubMed ID: 29861388
[TBL] [Abstract][Full Text] [Related]
16. CNS β
Richard JE; López-Ferreras L; Chanclón B; Eerola K; Micallef P; Skibicka KP; Wernstedt Asterholm I
Am J Physiol Endocrinol Metab; 2017 Sep; 313(3):E344-E358. PubMed ID: 28588096
[TBL] [Abstract][Full Text] [Related]
17. Comparative effects of the long-acting GLP-1 receptor ligands, liraglutide and exendin-4, on food intake and body weight suppression in rats.
Hayes MR; Kanoski SE; Alhadeff AL; Grill HJ
Obesity (Silver Spring); 2011 Jul; 19(7):1342-9. PubMed ID: 21415845
[TBL] [Abstract][Full Text] [Related]
18. Long-acting glucagon-like peptide-1 receptor agonists have direct access to and effects on pro-opiomelanocortin/cocaine- and amphetamine-stimulated transcript neurons in the mouse hypothalamus.
Knudsen LB; Secher A; Hecksher-Sørensen J; Pyke C
J Diabetes Investig; 2016 Apr; 7 Suppl 1(Suppl 1):56-63. PubMed ID: 27186357
[TBL] [Abstract][Full Text] [Related]
19. Robust anti-obesity and metabolic effects of a dual GLP-1/glucagon receptor peptide agonist in rodents and non-human primates.
Henderson SJ; Konkar A; Hornigold DC; Trevaskis JL; Jackson R; Fritsch Fredin M; Jansson-Löfmark R; Naylor J; Rossi A; Bednarek MA; Bhagroo N; Salari H; Will S; Oldham S; Hansen G; Feigh M; Klein T; Grimsby J; Maguire S; Jermutus L; Rondinone CM; Coghlan MP
Diabetes Obes Metab; 2016 Dec; 18(12):1176-1190. PubMed ID: 27377054
[TBL] [Abstract][Full Text] [Related]
20. Liraglutide Modulates Appetite and Body Weight Through Glucagon-Like Peptide 1 Receptor-Expressing Glutamatergic Neurons.
Adams JM; Pei H; Sandoval DA; Seeley RJ; Chang RB; Liberles SD; Olson DP
Diabetes; 2018 Aug; 67(8):1538-1548. PubMed ID: 29776968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
